Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGER | Q15109 | 8/20 | 0.67 |
| ▸ | MAPT | P10636 | 3/20 | 0.65 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.62 |
| ▸ | IDO1 | P14902 | 1/20 | 0.60 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.59 |
| ▸ | FDPS | P14324 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 4/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | APAF1 | O14727 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30719991 | 0.85 | AGER (0.65) | AGERMAPTMAPK1TSHRPOLB | |
| SCHEMBL25297849 | 0.85 | AGER (0.65) | AGERMAPTMAPK1TSHRPOLB | |
| SCHEMBL6791275 | 0.84 | GGPS1 (0.64) | AGERMAPTMAPK1TSHRPOLB | |
| SCHEMBL16603976 | 0.81 | IDO1 (0.74) | AGERMAPTMAPK1TSHRPOLB | |
| SCHEMBL18069502 | 0.81 | AGER (0.64) | AGERMAPTMAPK1TSHRPOLB | |
| SCHEMBL16603963 | 0.81 | BACE1 (0.65) | AGERMAPTMAPK1TSHRPOLB | |
| SCHEMBL6176569 | 0.81 | APAF1 (0.68) | AGERMAPTMAPK1TSHRPOLB | |
| SCHEMBL6175278 | 0.81 | APAF1 (0.68) | AGERMAPTMAPK1TSHRPOLB | |
| SCHEMBL16603990 | 0.80 | AGER (1.00) | AGERMAPTMAPK1TSHRPOLB | |
| SCHEMBL16603995 | 0.80 | AGER (1.00) | AGERMAPTMAPK1TSHRPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105849210-B | Dispersants having multiple aromatic imide anchoring groups | 路博润先进材料公司 | 2019-12-13 | — | — | CN | disclosed |
| US-10442884-B2 | Dispersants with multiple aromatic imide anchor groups | LUBRIZOL ADVANCED MATERIALS, INC. (US) | 2019-10-15 | — | — | US | disclosed |
| US-20160237196-A1 | DISPERSANTS WITH MULTIPLE AROMATIC IMIDE ANCHOR GROUPS | LUBRIZOL ADVANCED MAT INC (US) | 2016-08-18 | — | — | US | disclosed |
| EP-1317445-B1 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS | ANORMED INC (CA) | 2009-03-11 | — | — | EP | disclosed |
| US-7396840-B2 | Chemokine receptor binding heterocyclic compounds | GENZYME CORPORATION (US) | 2008-07-08 | — | — | US | disclosed |
| EP-1089809-B1 | POLYURETHANE DISPERSANTS | LUBRIZOL CORP (US) | 2006-10-18 | — | — | EP | disclosed |
| US-7084155-B2 | Chemokine receptor binding heterocyclic compounds | ANORMED (CA) | 2006-08-01 | — | — | US | disclosed |
| US-20060128750-A1 | Chemokine receptor binding heterocyclic compounds | GENZYME CORPORATION | 2006-06-15 | — | — | US | disclosed |
| US-6864265-B2 | Chemokine receptor binding heterocyclic compounds | ANORMED, INC. (CA) | 2005-03-08 | — | — | US | disclosed |
| US-20040220207-A1 | Chemokine receptor binding heterocyclic compounds | GENZYME CORPORATION | 2004-11-04 | — | — | US | disclosed |
| EP-1317445-A2 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS | ANORMED INC. (CA) | 2003-06-11 | — | — | EP | disclosed |
| US-20030018046-A1 | Chemokine receptor binding heterocyclic compounds | GENZYME CORPORATION | 2003-01-23 | — | — | US | disclosed |
| US-6509409-B1 | A dispersant comprising the addition product of a polyisocyanate having an average functionality of from 2 to 10 and one or more poly(oxyalkylene carbonyl) chains (POAC chain) such as those containing a POAC chain derived from | AVECIA LIMITED (GB) | 2003-01-21 | — | — | US | disclosed |
| EP-0956153-B1 | DISPERSING AGENT | EFKA ADDITIVES B V (NL) | 2002-10-02 | — | — | EP | disclosed |
| WO-2002022600-A2 | CHEMOKINE RECEPTOR BINDING HETEROCYCLIC COMPOUNDS | ANORMED INC. (CA) | 2002-03-21 | — | — | WO | disclosed |
| EP-0956153-A1 | DISPERSING AGENT | Ekfa Chemicals B.V. (NL) | 1999-11-17 | — | — | EP | disclosed |
| US-5882393-A | REACTION PRODUCT OF POLYISOCYANATES WITH A COMPOUND OF RING STRUCTURE WITH AT LEAST ONE NITROGEN ATOM IN RING; LACQUER | EFKA CHEMICALS B.V. (NL) | 1999-03-16 | — | — | US | disclosed |
| WO-1997026984-A1 | DISPERSING AGENT | EKFA CHEMICALS B.V. (NL) | 1997-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040220207-A1 | Chemokine receptor binding heterocyclic compounds | CXCR3, ACKR3, CCR2 | AGER 648/4885MAPT 4540/4885MAPK1 1891/4885 |
| US-20060128750-A1 | Chemokine receptor binding heterocyclic compounds | CXCR4, CCR5, CXCR3 | AGER 618/4885MAPT 4266/4885MAPK1 2094/4885 |
| US-20030018046-A1 | Chemokine receptor binding heterocyclic compounds | CXCR3, ACKR3, CCR2 | AGER 648/4885MAPT 4540/4885MAPK1 1891/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.